VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 215 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,142,798 | -14.6% | 762,305 | +123.6% | 0.00% | 0.0% |
| Q2 2023 | $8,362,325 | -41.1% | 340,902 | -44.1% | 0.00% | 0.0% |
| Q1 2023 | $14,188,069 | +9.9% | 609,715 | +19.6% | 0.00% | 0.0% |
| Q4 2022 | $12,904,378 | +53.5% | 509,853 | +16.9% | 0.00% | 0.0% |
| Q3 2022 | $8,408,000 | +67.6% | 436,090 | +121.4% | 0.00% | 0.0% |
| Q2 2022 | $5,016,000 | -61.1% | 196,944 | -60.7% | 0.00% | 0.0% |
| Q1 2022 | $12,890,000 | +1.3% | 501,179 | +64.9% | 0.00% | 0.0% |
| Q4 2021 | $12,725,000 | +47.0% | 303,905 | +52.8% | 0.00% | 0.0% |
| Q3 2021 | $8,656,000 | -21.7% | 198,883 | -14.9% | 0.00% | 0.0% |
| Q2 2021 | $11,048,000 | +20.5% | 233,674 | +30.7% | 0.00% | 0.0% |
| Q1 2021 | $9,166,000 | +647.6% | 178,786 | +290.5% | 0.00% | – |
| Q4 2020 | $1,226,000 | +42.9% | 45,788 | +83.2% | 0.00% | – |
| Q3 2020 | $858,000 | -54.8% | 24,987 | -46.1% | 0.00% | – |
| Q2 2020 | $1,899,000 | +3118.6% | 46,356 | +2587.3% | 0.00% | – |
| Q1 2020 | $59,000 | +321.4% | 1,725 | +54.6% | 0.00% | – |
| Q4 2019 | $14,000 | – | 1,116 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |